Publications by authors named "F Baltaro"
Significance of low birthweight for gestational age among very preterm infants.
Br J Obstet Gynaecol
June 1997
Article Synopsis
- - The study investigates the relationship between low birthweight and adverse neonatal outcomes in very preterm infants born between 24 to 31 weeks gestation in Pavia, Italy.
- - Analyzed data from 230 singleton infants showed that lower birthweight standard deviation scores (SDS) are linked to a higher risk of neonatal death and other severe complications such as intraventricular hemorrhage and respiratory distress syndrome.
- - While low birthweight increases the risk of these negative outcomes, the study concludes that gestational age has a more significant impact on neonatal outcomes than birthweight does.
Objective: To evaluate the efficacy of one-day, intermittent, monthly prophylaxis with 400 mg itraconazole in the management of recurrent vulvovaginal candidiasis.
Study Design: In a randomized trial, 57 patients and 57 controls with recurrent vulvovaginal candidiasis were assigned either to receive one-day monthly itraconazole prophylaxis for six months or no treatment. Clinical and mycologic evaluations were carried out 3, 6 and 12 months after enrollment.
The prevalence of oral contraceptive use in association with chlamydial pelvic inflammatory disease (PID) and the presence of anti-chlamydial IgG and IgA in a population of 144 hospitalized and outpatient subjects with a standard diagnosis of PID was studied. The rates of chlamydial PID and IgA detection were 15.3% (22/144) and 13.
View Article and Find Full Text PDFCervical intraepithelial neoplasia in pregnant intravenous drug users infected with human immunodeficiency virus type 1.
Eur J Obstet Gynecol Reprod Biol
September 1996
Objective: The purpose of this study was to evaluate the frequency and natural history of cervical intraepithelial neoplasia (CIN) during pregnancy in past or current intravenous drug users infected with human immunodeficiency virus type 1 (HIV-1).
Study Design: We prospectively evaluated 48 pregnant HIV-1 seropositive patients and 38 HIV seronegative controls. All the subjects were current or past intravenous drug users.